SCHEMBL21632672

SCHEMBL21632672

C[C@H](Cc1cccc(C(F)(F)F)c1)NCCc1ccccc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 14/20 0.85
▸ CYP3A4 P08684 3/20 0.85
▸ CYP1A2 P05177 2/20 0.85
▸ CYP2D6 P10635 2/20 0.85
▸ TP53 P04637 1/20 0.85
▸ TSHR P16473 1/20 0.85
▸ CYP2C19 P33261 1/20 0.85
▸ HTR2A P28223 3/20 0.70
▸ HTR2B P41595 3/20 0.70
▸ ADRA2C P18825 2/20 0.70
▸ SLC6A4 P31645 2/20 0.70
▸ ADRA1A P35348 2/20 0.70
▸ DRD3 P35462 2/20 0.70
▸ LMNA P02545 1/20 0.70
▸ MAPT P10636 1/20 0.70
▸ OPRK1 P41145 1/20 0.70
▸ USP2 O75604 2/20 0.65
▸ HTR2C P28335 2/20 0.65
▸ NR1I2 O75469 1/20 0.65
▸ ADRB1 P08588 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12648288 0.92 SIGMAR1 (1.00) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
Hydrochloric Acid SCHEMBL8091253 0.91 SIGMAR1 (0.97) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
SCHEMBL14291920 0.86 SIGMAR1 (0.78) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
SCHEMBL9156429 0.86 SIGMAR1 (0.74) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
SCHEMBL19001393 0.86 SIGMAR1 (0.74) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
SCHEMBL24141657 0.86 SIGMAR1 (0.78) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
SCHEMBL9472690 0.86 SIGMAR1 (0.74) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
SCHEMBL9248064 0.86 SIGMAR1 (0.74) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
SCHEMBL6422930 0.84 SIGMAR1 (0.72) SIGMAR1CYP3A4CYP1A2CYP2D6TP53
Hydrochloric Acid SCHEMBL4685694 0.84 SIGMAR1 (0.76) SIGMAR1CYP3A4CYP1A2CYP2D6TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3829558-A1 METHOD FOR TREATING EPILEPSY Xenon Pharmaceuticals Inc. (CA) 2021-06-09 — — EP disclosed
WO-2020023923-A1 METHOD FOR TREATING EPILEPSY XENON PHARMACEUTICALS INC. (CA) 2020-01-30 — — WO disclosed
Send feedback